[Research progress in coagulation dysfunction and its relationship with cytokine storm syndrome in patients with severe/critical COVID-19].
作者信息
Zhang J, Gao X L, Yang L H
机构信息
Shanxi Medical University, Taiyuan 030001.
Department of Respiratory and Critical Care Medicine, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2021 Aug 14;42(8):700-704. doi: 10.3760/cma.j.issn.0253-2727.2021.08.019.
Abstract
摘要
相似文献
1
[Research progress in coagulation dysfunction and its relationship with cytokine storm syndrome in patients with severe/critical COVID-19].[重型/危重型新型冠状病毒肺炎患者凝血功能障碍及其与细胞因子风暴综合征关系的研究进展]
Zhonghua Xue Ye Xue Za Zhi. 2021 Aug 14;42(8):700-704. doi: 10.3760/cma.j.issn.0253-2727.2021.08.019.
2
Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?炎症衰老和凝血衰老是否在导致 COVID-19 老年人中严重炎症状态和致命性凝血障碍同时发生的条件中起作用？
Exp Gerontol. 2021 Aug;151:111423. doi: 10.1016/j.exger.2021.111423. Epub 2021 May 26.
3
Mixed storm in SARS-CoV-2 infection: A narrative review and new term in the Covid-19 era.SARS-CoV-2 感染中的混合性炎症风暴：Covid-19 时代的叙述性综述和新术语。
Immun Inflamm Dis. 2023 Apr;11(4):e838. doi: 10.1002/iid3.838.
4
The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.关键促炎细胞因子在新型冠状病毒感染期间细胞因子风暴形成过程中的作用。
J Med Virol. 2023 Apr;95(4):e28751. doi: 10.1002/jmv.28751.
5
Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).新型冠状病毒病 2019（COVID-19）中的血管内皮细胞功能障碍、凝血和血管生成。
Microvasc Res. 2021 Sep;137:104188. doi: 10.1016/j.mvr.2021.104188. Epub 2021 May 20.
6
Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.巴瑞替尼，一种具有潜在作用的药物，可以阻止 SARS-COV-2 进入靶细胞，并控制由 COVID-19 引起的细胞因子风暴。
Int Immunopharmacol. 2020 Sep;86:106749. doi: 10.1016/j.intimp.2020.106749. Epub 2020 Jul 1.
7
Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.细胞因子和趋化因子在 SARS-CoV-2 感染中的作用-靶向细胞因子风暴的治疗策略。
Biomolecules. 2021 Jan 12;11(1):91. doi: 10.3390/biom11010091.
8
Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.COVID-19 相关急性呼吸窘迫综合征和肺外多器官功能障碍患者炎症细胞因子风暴中的特定细胞因子。
Virol J. 2021 Jun 4;18(1):117. doi: 10.1186/s12985-021-01588-y.
9
Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm.作为一种治疗策略，针对 SARS-CoV-2 诱导的细胞因子风暴对 IRAK 酶进行调节。
Clin Exp Med. 2023 Oct;23(6):2909-2923. doi: 10.1007/s10238-023-01064-7. Epub 2023 Apr 15.
10
Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.细胞因子风暴：它是新冠病毒肺炎患者唯一的主要死亡因素吗？凝血作用。
Med Hypotheses. 2020 Sep;142:109829. doi: 10.1016/j.mehy.2020.109829. Epub 2020 May 12.
引用本文的文献
1
Dynamic changes in platelet counts and psychological state in ITP patients after COVID-19 infection.COVID-19感染后ITP患者血小板计数及心理状态的动态变化
Front Med (Lausanne). 2025 Mar 14;12:1485418. doi: 10.3389/fmed.2025.1485418. eCollection 2025.
本文引用的文献
1
Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19.重组 ADAMTS13 降低重症 COVID-19 患者血浆中异常上调的 von Willebrand 因子。
Thromb Res. 2021 May;201:100-112. doi: 10.1016/j.thromres.2021.02.012. Epub 2021 Feb 18.
2
The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?COVID-19 发病机制中的促炎细胞因子：出了什么问题？
Microb Pathog. 2021 Apr;153:104799. doi: 10.1016/j.micpath.2021.104799. Epub 2021 Feb 18.
3
Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection.新型冠状病毒感染相关凝血功能障碍的风险管理与治疗
Int J Environ Res Public Health. 2021 Jan 31;18(3):1268. doi: 10.3390/ijerph18031268.
4
The Role of TEG Analysis in Patients with COVID-19-Associated Coagulopathy: A Systematic Review.血栓弹力图分析在新型冠状病毒肺炎相关凝血病患者中的作用：一项系统评价
Diagnostics (Basel). 2021 Jan 26;11(2):172. doi: 10.3390/diagnostics11020172.
5
Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.炎症和血液学标志物作为 COVID-19 感染严重结局的预测因子：系统评价和荟萃分析。
Am J Emerg Med. 2021 Mar;41:110-119. doi: 10.1016/j.ajem.2020.12.076. Epub 2020 Dec 30.
6
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.COVID-19、免疫血栓形成和静脉血栓栓塞症：生物学机制。
Thorax. 2021 Apr;76(4):412-420. doi: 10.1136/thoraxjnl-2020-216243. Epub 2021 Jan 6.
7
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review.患有急性呼吸窘迫综合征的危重症 COVID-19 患者的凝血障碍：一项批判性综述
J Clin Med. 2021 Jan 3;10(1):140. doi: 10.3390/jcm10010140.
8
Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor.新型冠状病毒2型感染中的凝血异常：组织因子过表达
Thromb J. 2020 Dec 15;18(1):38. doi: 10.1186/s12959-020-00250-x.
9
The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease.新冠病毒疾病中失调的免疫反应和细胞因子释放风暴（CRS）。
Int Immunopharmacol. 2021 Jan;90:107225. doi: 10.1016/j.intimp.2020.107225. Epub 2020 Nov 27.
10
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.TNF-α 和 IFN-γ 的协同作用可引发 SARS-CoV-2 感染和细胞因子休克综合征中的炎症细胞死亡、组织损伤和死亡。
Cell. 2021 Jan 7;184(1):149-168.e17. doi: 10.1016/j.cell.2020.11.025. Epub 2020 Nov 19.
Zotero 插件